Hide Board Information

Show Board Information

DigitalOcean Holdings Inc. DOCN

Board Mod: Add me as mod

Asst Mods:

Last Post: 05/22/2025 3:29:26 AM

Board Marks: 0

Posts Today: 2

Board Views Today: 128

DigitalOcean Holdings Inc. (NYSE: DOCN) Stock Message Board

1. DOCN Company Profile

    

2. DOCN Time & Sales

    

3. DOCN Recent News

    

4. DOCN Filings

    

5. DOCN Financials

    

6. DOCN Buy Rating

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

4	If you're constantly seeing error codes in	Arthurcole121	05/22/2025 3:29:26 AM
3	Losing important financial data in QuickBooks	Arthurcole121	05/22/2025 3:21:31 AM
2	Thanks for sharing, I am very impressed with your	Malley	04/30/2025 11:59:49 PM
1	$DOCN Q4 FY24 Earnings Recap	EarningsCentral	02/25/2025 11:21:23 PM

Recent Articles

• Johnson & Johnson's IMAAVY Hits Myasthenia Gravis Market
• Cohen & Steers Total Return Realty Fund Updates for Investors
• SFC Enhances Community Engagement with New Ice Rink Management
• Boehringer Ingelheim Unveils Promising Cancer Trials at ASCO 2025
• Soleno Therapeutics Advances in Treating Hyperphagia for PWS
• Embracing Peace Through Collective Prayer and Support
• Understanding Distribution Sources for Cohen & Steers' Fund
• Innovative Cancer Research from RWJBarnabas Health Surfaces
• Abeona's ZEVASKYN Breakthrough: A New Hope for DEB Patients
• Silvercorp Exhibits Strong Fiscal Year-End Performance 2025
• Univest Securities Completes $5 Million Offering for WORK Medical Tech
• Kura Oncology and Kyowa Kirin Unveil Ziftomenib Trial Findings
• Merus Showcases Promising Efficacy of Petosemtamab with Pembrolizumab
• Iovance Biotherapeutics Reveals 5-Year Study on Amtagvi® Efficacy
• Daktronics Engages at Leading Investor Conference This May
• Allogene Therapeutics Shares Key ASCO 2025 Abstracts on CAR T Developments
• IMUNON Seeks to Withdraw Registration Amid Growth Plans
• Abcourt Mines Inc. Reports Solid Third Quarter Progress
• PDS Biotech Shares Positive Results for Versamune® HPV Treatments
• Servotronics' Proxy Contest Conclusion and Upcoming Meeting
• Haivision to Unveil Financial Insights for Q2 Fiscal 2025
• M-tron Industries, Inc. Announces Upcoming Investor Meeting
• Rigel Pharmaceuticals Set for Major Presentations at ASCO 2025
• Investors Can Join Digimarc Corporation Class Action Today
• ImCheck Therapeutics Showcases Promising AML Therapy Results
• Legend Biotech Reveals Significant Updates in Cancer Treatment
• ROHM Introduces Next-Gen Compact NIR LEDs for Advanced Applications
• Cullinan Therapeutics and Partners Showcase Breakthrough Cancer Trial Findings
• Biodesix Unveils Promising Data on VeriStrat Test for NSCLC
• Acceleware Ltd. Achieves Significant Progress in Q1 2025
• Genmab Unveils Late-Stage Data Ahead of ASCO 2025 Meeting
• Petrus Resources Shares Success of Annual Meeting Outcomes
• Exciting Phase 2 Results from Actuate's Elraglusib in Cancer Treatment
• Candel Therapeutics Advances Localized Prostate Cancer Treatment
• Adagene Showcases Promising Results for ADG126 in Cancer Trials
• Banco Comercial Português Highlights Key AGM Resolutions
• Wheaton Precious Metals Unveils 2024 Reports on Sustainability and Climate
• Novita Reports Encouraging Phase 2 Trial Results for NP-G2-044
• Accent Therapeutics Showcases Innovative Cancer Treatment Advances
• Cizzle Bio's CIZ1B Test Offers Significant Medicare Savings
• Ontario International Airport Sees Record Passenger Growth
• Foresight Diagnostics Validates CLARITY MRD Assay for DLBCL
• XTANDI™ Breakthrough: Prostate Cancer Patients See 30% Survival Increase
• Servier Showcases Commitment to IDH-Mutated Cancer Research
• West Fraser Timber's Commitment to Sustainability in 2024
• Boehringer Ingelheim's Ambitious Plan for Future Cancer Innovations
• Taiho Oncology Unveils Groundbreaking Cancer Therapy Data
• Eli Lilly Unveils Research Presentations for ASCO 2025 Meeting
• COOFANDY Celebrates a Decade of Excellence with Major Awards
• Unlocking Earning Potential: FioBit's AI Mining Revolution 2025